113 related articles for article (PubMed ID: 35790271)
1. Up-regulation of CPNE1 Appears to Enhance Cancer Progression in HER2-positive and Luminal A Breast Cancer Cells.
Choi HY; Lee HJ; Moon KM; Moon DK; Lee S; Park H; Hong J; Park MJ; Woo DK; Yoo JC
Anticancer Res; 2022 Jul; 42(7):3445-3452. PubMed ID: 35790271
[TBL] [Abstract][Full Text] [Related]
2. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
3. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling.
Cao J; Cao R; Liu Y; Dai T
Pathol Res Pract; 2023 Aug; 248():154634. PubMed ID: 37454492
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
5. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Wang A; Yang W; Li Y; Zhang Y; Zhou J; Zhang R; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2022 Jan; 20(1):16. PubMed ID: 35101055
[TBL] [Abstract][Full Text] [Related]
6. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
[TBL] [Abstract][Full Text] [Related]
9. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
[TBL] [Abstract][Full Text] [Related]
10. Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.
Lee J; Park HY; Kim WW; Lee SJ; Jeong JH; Kang SH; Jung JH; Chae YS
Tumour Biol; 2017 Jun; 39(6):1010428317707374. PubMed ID: 28653903
[TBL] [Abstract][Full Text] [Related]
11. CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
Liang J; Zhang J; Ruan J; Mi Y; Hu Q; Wang Z; Wei B
Med Sci Monit; 2017 Nov; 23():5504-5514. PubMed ID: 29151113
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.
Hosonaga M; Arima Y; Sugihara E; Kohno N; Saya H
Cancer Sci; 2014 Jul; 105(7):779-87. PubMed ID: 24754246
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells.
Kim H; Kim HS; Moon WK
Toxicol Appl Pharmacol; 2019 Dec; 385():114814. PubMed ID: 31715268
[TBL] [Abstract][Full Text] [Related]
14. Role of CPNE1 in Odontoblastic Differentiation of Rat Stem Cells from Apical Papilla.
Lu X; Xie H; Ju Y; Fu Y; Liu S; Zhao S
Adv Biol (Weinh); 2023 Jul; 7(7):e2300054. PubMed ID: 37132099
[TBL] [Abstract][Full Text] [Related]
15. CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Tang H; Zhu J; Du W; Liu S; Zeng Y; Ding Z; Zhang Y; Wang X; Liu Z; Huang J
J Exp Clin Cancer Res; 2018 Jul; 37(1):131. PubMed ID: 29970127
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
Niu G; Carter WB
Cancer Res; 2007 Feb; 67(4):1487-93. PubMed ID: 17308086
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.
Zhang W; Ding W; Chen Y; Feng M; Ouyang Y; Yu Y; He Z
Acta Biochim Biophys Sin (Shanghai); 2011 Aug; 43(8):647-53. PubMed ID: 21712253
[TBL] [Abstract][Full Text] [Related]
18. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.
Xu C; Chen H; Wang X; Gao J; Che Y; Li Y; Ding F; Luo A; Zhang S; Liu Z
J Biol Chem; 2014 Jan; 289(2):827-37. PubMed ID: 24285542
[TBL] [Abstract][Full Text] [Related]
19. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]